Drug Discovery Technologies Market Report 2026

Drug Discovery Technologies Market Overview

• Drug Discovery Technologies market size has reached to $80.76 billion in 2025 • Expected to grow to $138.44 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Rising Healthcare Expenditures Fuel Growth In The Drug Discovery Technologies Market • Market Trend: Key Players Innovations Enhance Drug Discovery Technologies Market Growth • North America was the largest region in 2025.

What Is Covered Under Drug Discovery Technologies Market?

Drug discovery technology refers to the various techniques and strategies used in discovering new drugs and identifying chemical entities with the potential to be medicines and therapeutic agents. These technologies aim to identify and develop potential drug candidates that can be used to treat diseases. The main types of drug discovery technologies are high-throughput screening, genomics, nanotechnology, bioinformatics, combinational chemistry, pharmacogenomics, biochips, bioanalytical instruments, and ribonucleic acid interface (RNAI). High-throughput screening is a technique for quickly determining the biological activity of tens of thousands to millions of samples and is used to accelerate drug discovery. These technologies are used in the discovery of drug types such as small molecule drugs and biologic drugs and for applications in diseases such as cancer diseases, immunological diseases, neurological diseases, cardiovascular diseases and others, which are used by pharmaceutical companies, biopharmaceutical companies, biotechnology companies, research institutes, and others.

What Is The Drug Discovery Technologies Market Growth Forecast?

The drug discovery technologies market size is expected to see rapid growth in the next few years. It will grow to $138.44 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to ai-driven molecular design, personalized medicine focus, advanced analytics integration, novel therapeutic modalities, accelerated discovery timelines. Major trends in the forecast period include growing adoption of high throughput screening, increased use of bioinformatics platforms, expansion of rna-based drug discovery, rising application of nanotechnology in drug design, integration of pharmacogenomics in discovery.

Global Drug Discovery Technologies Market Segmentation

1) By Technology: High Throughput Screening, Genomics, Nanotechnology, Bioinformatics, Combinational Chemistry, Pharmacogenomics, Biochips, Bioanalytical Instruments, Ribonucleic Acid Interface (RNAI) 2) By Drug Type: Small Molecule Drugs, Biologic Drugs 3) By Disease Application: Cancer Diseases, Immunological Diseases, Neurological Diseases, Cardiovascular Diseases, Other Disease Applications 4) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Biotechnology Companies, Research Institutes, Other End-Users Subsegments: 1) By High Throughput Screening: Automated Screening Systems, Assay Development 2) By Genomics: DNA Sequencing, Genomic Data Analysis 3) By Nanotechnology: Nanoparticle-Based Drug Delivery, Nanomaterials For Drug Formulation 4) By Bioinformatics: Data Analysis Tools, Computational Biology Software 5) By Combinational Chemistry: Library Synthesis Techniques, Screening Methods 6) By Pharmacogenomics: Genetic Testing Platforms, Personalized Medicine Applications 7) By Biochips: Microarrays, Lab-On-A-Chip Technologies 8) By Bioanalytical Instruments: Mass Spectrometry, Chromatography Systems 9) By Ribonucleic Acid Interface (RNAI): RNA Interference Technologies, Therapeutic RNA Applications

What Is The Driver Of The Drug Discovery Technologies Market?

The rise in healthcare expenditures is expected to propel the growth of the drug discovery technologies market going forward. Healthcare expenditures refer to the total financial resources allocated to medical services, public health initiatives, family planning, nutritional programs, and emergency health support. Healthcare spending continues to increase due to growing demand for advanced treatments, aging populations, chronic disease burdens, and broader access to healthcare services. The drug discovery technologies supports this trend by using increased funding to enhance research platforms, analytical tools, and digital technologies that accelerate therapeutic innovation. For instance, in May 2024, according to Office of National Statistics a UK-based government agency, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, compared with growth of 0.9% in 2022. Therefore, the rise in healthcare expenditures is driving the growth of the drug discovery technologies industry.

Key Players In The Global Drug Discovery Technologies Market

Major companies operating in the drug discovery technologies market are F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrödinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc.

Global Drug Discovery Technologies Market Trends and Insights

Major companies operating in the drug discovery technologies market are focusing on developing advanced solutions such as drug research and development platforms to improve precision, enhance high-throughput analysis, and accelerate the discovery of new therapeutic compounds. A drug research and development platform refers to an integrated framework that streamlines the processes of identifying, designing, optimizing, and validating pharmaceutical candidates through unified workflows and data-driven tools. For instance, in July 2023, Dotmatics Inc., a US-based scientific software company, launched the Small Molecule Drug Discovery Solution, a comprehensive R&D platform featuring pre-configured workflows and enhanced data management capabilities designed to foster collaboration, boost productivity, and streamline operations. This platform enables researchers to efficiently transform data into actionable insights and supports a cohesive workspace from hit discovery through lead optimization, accelerating the development of life-enhancing drug therapies.

What Are Latest Mergers And Acquisitions In The Drug Discovery Technologies Market?

In June 2024, Simulations Plus Inc., a US-based software company, acquired Pro-ficiency Holdings Inc. for $100 million. Through this acquisition, Simulations Plus aims to expand its drug discovery and development capabilities by integrating simulation-based learning, intelligence, and compliance solutions to enhance clinical trial operations, commercialization efforts, and data analytics. Pro-ficiency Holdings Inc. is a US-based company that provides simulation-based learning and compliance solutions for the life sciences industry, including drug discovery technologies.

Regional Outlook

North America was the largest region in the drug discovery technologies market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Discovery Technologies Market?

The drug discovery technologies market consists of revenues earned by entities by drug screening, predictive analytics, modeling, simulation, and computational capabilities. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug discovery technologies market also includes sales of automation tools, computational chemistry software, imaging software, and mass spectrometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Discovery Technologies Market Report 2026?

The drug discovery technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.